Eliyahu Sharon Kalif, Executive Vice President and Chief Financial Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), has sold 345,810 shares of the company's stock. The transaction, which occurred on February 26, 2026, was valued at approximately $11,633,048, with shares sold at $33.64 each.
This sale represents a significant disposition of shares by a key executive. Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or pre-arranged trading plans, and do not necessarily indicate a negative view of the company's future prospects.
The sale by Kalif is part of a recent pattern of insider selling activity at TEVA. Over the past few months, other executives, including Richard D. Francis and Roberto Mignone, have also reported selling shares in the company.